JP2002518468A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002518468A5 JP2002518468A5 JP2000555854A JP2000555854A JP2002518468A5 JP 2002518468 A5 JP2002518468 A5 JP 2002518468A5 JP 2000555854 A JP2000555854 A JP 2000555854A JP 2000555854 A JP2000555854 A JP 2000555854A JP 2002518468 A5 JP2002518468 A5 JP 2002518468A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- desformoterol
- pharmaceutically acceptable
- following formula
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- KFWXDCVTOHBISX-UHFFFAOYSA-N CC1(CCCCCNCC2(CC2)c(cc2)cc(C)c2O)C=CC(OC)=CC1 Chemical compound CC1(CCCCCNCC2(CC2)c(cc2)cc(C)c2O)C=CC(OC)=CC1 KFWXDCVTOHBISX-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/103,212 | 1998-06-23 | ||
| US09/103,212 US5965622A (en) | 1998-06-23 | 1998-06-23 | Desformoterol and process for its preparation |
| PCT/US1999/014082 WO1999067198A1 (en) | 1998-06-23 | 1999-06-22 | Desformoterol and process for its preparation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002518468A JP2002518468A (ja) | 2002-06-25 |
| JP2002518468A5 true JP2002518468A5 (https=) | 2006-07-13 |
| JP4328021B2 JP4328021B2 (ja) | 2009-09-09 |
Family
ID=22293976
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000555854A Expired - Lifetime JP4328021B2 (ja) | 1998-06-23 | 1999-06-22 | デスフォルモテロール及びその製造方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US5965622A (https=) |
| EP (1) | EP1093450B1 (https=) |
| JP (1) | JP4328021B2 (https=) |
| AT (1) | ATE238271T1 (https=) |
| AU (1) | AU747329B2 (https=) |
| CA (1) | CA2335154C (https=) |
| DE (1) | DE69907190T2 (https=) |
| ES (1) | ES2193722T3 (https=) |
| WO (1) | WO1999067198A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20010428A1 (it) * | 2001-03-02 | 2002-09-02 | Chemo Breath S A | Composizioni ad uso inalatorio a base di formoterolo |
| US6667344B2 (en) | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
| US20030055026A1 (en) * | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
| US20040023935A1 (en) * | 2002-08-02 | 2004-02-05 | Dey, L.P. | Inhalation compositions, methods of use thereof, and process for preparation of same |
| US20050158248A1 (en) * | 2002-08-21 | 2005-07-21 | Xian-Ming Zeng | Method of preparing dry powder inhalation compositions |
| AU2003269989B8 (en) * | 2002-08-21 | 2009-11-12 | Norton Healthcare Ltd. | Inhalation composition |
| GB0219511D0 (en) * | 2002-08-21 | 2002-10-02 | Norton Healthcare Ltd | Method of preparing dry powder inhalation compositions |
| US20040109826A1 (en) * | 2002-12-06 | 2004-06-10 | Dey, L.P. | Stabilized albuterol compositions and method of preparation thereof |
| TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
| WO2008035380A2 (en) * | 2006-09-19 | 2008-03-27 | Natco Pharma Limited | An improved process for the preparation of high purity formoterol and its pharmaceutically acceptable salts |
| CN101391962A (zh) * | 2007-09-21 | 2009-03-25 | 北京德众万全药物技术开发有限公司 | 一种高纯度的(R)-α-(溴甲基)-4-苄氧基-3-硝基苯甲醇及其制备方法 |
| CN101462971B (zh) * | 2007-12-19 | 2014-05-07 | 北京德众万全药物技术开发有限公司 | 高纯度的用于制备福莫特罗的关键中间体及其制备方法 |
| ES2539947T3 (es) | 2008-06-02 | 2015-07-07 | Cipla Limited | Procedimiento para la síntesis de arformoterol |
| WO2010128355A2 (en) | 2008-12-26 | 2010-11-11 | Actavis Group Ptc Ehf | Improved processes for preparing substantially pure arformoterol and its intermediates |
| US8282512B1 (en) | 2009-03-26 | 2012-10-09 | Warrior Sports, Inc. | Lacrosse head |
| CN101921200B (zh) * | 2009-06-16 | 2014-01-15 | 上海医药工业研究院 | 一种n-苄基-1-(4-甲氧基苯基)-2-丙胺的制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2031407A6 (es) * | 1988-10-05 | 1992-12-01 | Lasa Lab | Mejoras introducidas en el objeto de la patente principal n{ 8703715 por: procedimiento de obtencion de n-(2-hidroxi-5-(1-hidroxi-2-((2-(4-metoxifenil)-1-metiletil)amino)etil)fenil)formamida". |
-
1998
- 1998-06-23 US US09/103,212 patent/US5965622A/en not_active Expired - Lifetime
-
1999
- 1999-05-05 US US09/305,534 patent/US6071971A/en not_active Expired - Lifetime
- 1999-06-22 CA CA002335154A patent/CA2335154C/en not_active Expired - Lifetime
- 1999-06-22 EP EP99930556A patent/EP1093450B1/en not_active Expired - Lifetime
- 1999-06-22 AT AT99930556T patent/ATE238271T1/de not_active IP Right Cessation
- 1999-06-22 AU AU47072/99A patent/AU747329B2/en not_active Expired
- 1999-06-22 DE DE69907190T patent/DE69907190T2/de not_active Expired - Lifetime
- 1999-06-22 WO PCT/US1999/014082 patent/WO1999067198A1/en not_active Ceased
- 1999-06-22 JP JP2000555854A patent/JP4328021B2/ja not_active Expired - Lifetime
- 1999-06-22 ES ES99930556T patent/ES2193722T3/es not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002518468A5 (https=) | ||
| CN1202865C (zh) | 增效组合物 | |
| JP2007506766A5 (https=) | ||
| US6225343B1 (en) | Compositions and methods comprising morphine gluconate | |
| JP2002523452A (ja) | 肺疾患の治療方法 | |
| JP2007522248A (ja) | てんかんおよび他のｃｎｓ障害の処置のための、ｎｍｄａレセプターアンタゴニストと抗てんかん薬との組み合わせ | |
| CN1137894A (zh) | 顽发克星在治疗妇女非抑郁下丘脑性经闭中的应用 | |
| CA2303815A1 (en) | N,n-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives in the treatment of pain | |
| EP3785698A1 (en) | Edaravone pharmaceutical composition | |
| CN101068571A (zh) | 改善透粘膜给药制剂的吸收的方法 | |
| JPWO2021202329A5 (https=) | ||
| JP7830540B2 (ja) | ｄ－アンフェタミン化合物、組成物、ならびにそれを作製および使用するためのプロセス | |
| US12599578B2 (en) | Compositions comprising enzyme-cleavable prodrugs and controlled release nafamostat and methods of use thereof | |
| RU2002105375A (ru) | Применение агонистов gabab рецепторов и их фармацевтически приемлемых производных для поддерживающей терапии никотин-зависимых пациентов | |
| US5708036A (en) | Method of treating premature uterine contractions using the optically active R(-)-isomer of albuterol | |
| US6538035B2 (en) | Use of tolterodine to treat asthma | |
| SK138095A3 (en) | Transdermal therapeutic system for the administration of serotonin agonists | |
| JP2005516898A5 (https=) | ||
| CN113453665A (zh) | 用于舌下和/或经颊施用的纳洛酮制剂 | |
| US20080160068A1 (en) | Method for a Medicinal Combination Treatment, and Medicament Combinations Suitable Therefor | |
| CA2247953A1 (en) | Method of treating undesired uterine contractions using optically pure r- or rr-isomers of adrenergic beta-2 agonists | |
| EA009935B1 (ru) | Новая синергетическая комбинация, включающая рофлумиласт и формотерол | |
| JP2002541190A (ja) | 気分障害治療用医薬を製造するためのオサネタントの使用 | |
| WO2006017354A1 (en) | Compositions of nicotinic agonists and therapeutic agents and methods for treating or preventing disease or pain | |
| JP2007500205A5 (https=) |